President
CurrentKaligent provides software products and services designed to help healthcare and life science customers derive data-driven insights that impact patient care and outcomes. As a wholly owned subsidiary of TGen, an institute with a legacy rooted in genomic research, translational discovery, and high performance computing, Kaligent is uniquely positioned to commercialize its IP for pharma, payers, and providers. Our work seeks to redefine the patient care experience and advocate for greater data stewardship, security and management.